Real-world data on ILUVIEN® (fluocinolone acetonide intravitreal implant) 0.19 mg

Video Series Featuring Daniel Kiernan, MD

Daniel Kiernan, MD discusses how he incorporates ILUVIEN into his practice when treating patients with persistent DME.

Treating persistent diabetic macular edema presentation by Daniel Kiernan, MD

Video Series Featuring Caesar Luo, MD

Caesar Luo, MD of Bay Area Retina Associates presents the impact of ILUVIEN on a monocular patient’s visual acuity and edema.

Monocular patient case study presentation by Caesar Luo, MD

Video Series Featuring Jessica McCluskey, MD

Jessica McCluskey, MD of Thomas Eye Group presents data from our Phase 3 (FAME) clinical trials of ILUVIEN. Learn what impact ILUVIEN had on retinal thickness, visual acuity, and how it releases fluocinolone acetonide for the treatment of DME for up to 36 months.

Featuring ILUVIEN Phase 3 Clinical Trial Data presentation by Jessica McCluskey, MD

Video Series Featuring Veeral Sheth, MD

Dr. Sheth shares details of an ILUVIEN patient case study showcasing clinical impact on visual acuity, edema, and treatment frequency.

See how Dr. Sheth uses ILUVIEN

Video Series Featuring Dilsher Dhoot, MD

Dr. Dhoot presents outcomes of real-world clinical data with ILUVIEN from the retrospective USER Study.

Watch Dr. Dhoot present USER data